Table: begin end state 1 11 cytoplasmic 12 29 transmembrane 30 34 non-cytoplasmic 35 55 transmembrane 56 94 cytoplasmic 95 114 transmembrane 115 120 non-cytoplasmic 121 141 transmembrane 142 162 cytoplasmic 163 186 transmembrane 187 192 non-cytoplasmic 193 212 transmembrane 213 223 cytoplasmic 224 244 transmembrane 245 257 non-cytoplasmic 258 279 transmembrane 280 287 cytoplasmic 288 308 transmembrane 309 327 non-cytoplasmic 328 349 transmembrane 350 366 cytoplasmic 367 388 transmembrane 389 467 non-cytoplasmic 468 487 transmembrane 488 512 cytoplasmic 513 532 transmembrane 533 544 non-cytoplasmic 545 569 transmembrane 570 575 cytoplasmic 576 599 transmembrane 600 643 non-cytoplasmic 644 665 transmembrane 666 688 cytoplasmic
Input: >AO353_13990 FitnessBrowser__pseudo3_N2E3:AO353_13990 MKNNNSLLRHLPWLVLAVVGACALGVVALRRGEAINALWIVVAAVAIYLVAYRYYSLFIA NNVMQLNPLRATPAVVNNDGLDYVPTNKHILFGHHFAAIAGAGPLVGPVLAAQMGYLPGT LWLIAGVVLAGAVQDFMVLFMSTRRNGRSLGDMVREEMGQIPGTIALFGCFLIMIIILAV LALIVVKALAESPWGIFTVMATIPIAMFMGVYMRYIRPGRIGEISIVGVLLLLGSIWLGG QIAADPVWAKAFSFTGIQITWMLIGYGFVAAVLPVWLILAPRDYLSTFLKIGTIVALAIG ILITMPVLKMPALTQFIDGTGPVWKGGLFPFLFITIACGAVSGFHALIASGTTPKLLDNE SNARYIGYGGMLMESFVAIMAMVAASVIEPGVYFAMNSPAAIVGGEVMQVAQTVSSWGFA ITPEALQAVAKDIGETTVLARAGGAPTLAVGIAQILHSVLPGENTMAFWYHFAILFEALF ILTAVDAGTRAGRFMLQDLLGSFVPALKRTESWTANLIATAGCVAMWGYLLYQGVIDPLG GINTLWPLFGISNQMLAGIALMLGTVVLIKMKRQRYIWVTLLPAAWLLICTTTAGFIKLF DANPAIGFLSLAKKYSDALANGQILAPAKDITQMQHVIYNAYTNATLTALFLFVVFSILF YAIKVGISAWGSKERTDKESPFQAIPEA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server